<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02030886</url>
  </required_header>
  <id_info>
    <org_study_id>TF-1302</org_study_id>
    <nct_id>NCT02030886</nct_id>
  </id_info>
  <brief_title>IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients</brief_title>
  <official_title>A Single-center, Open Label, Prospective Study Assessing the 24-hour IOP Patterns Using SENSIMED Triggerfish® in Ocular Hypertensive Patients Newly Converted to Glaucomatous Disease Versus Stable Ocular Hypertensive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sensimed AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sensimed AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the relationship between IOP pattern as recorded over&#xD;
      24 hours by using Triggerfish and quantified by acrophase scored dichotomously, and&#xD;
      conversion to glaucoma in OHT patients (conversion status). Elevation of IOP above normal&#xD;
      range is called &quot;ocular hypertension&quot; (OHT). In a previous study, it has been shown that OHT&#xD;
      patients who progress to glaucoma (converters) have at baseline and prior to any conversion,&#xD;
      IOP patterns that more closely resemble those of established early primary open-angle&#xD;
      glaucoma (POAG) patients, while stable OHT patients (non-converters) have IOP patterns closer&#xD;
      to those of healthy control subjects. The study has been planned to recruit at least 48&#xD;
      eligible patients (24 converters and 24 non-converters).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low recruitment rate&#xD;
  </why_stopped>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relationship Between Intraocular Pressure (IOP) Pattern as Recorded by TF, and Quantified by Acrophase Scored Dichotomously, and Conversion to Glaucoma in Ocular Hypertension (OHT) Patients (Conversion Status)</measure>
    <time_frame>24 hours</time_frame>
    <description>For each subject, TF acrophase (ie. time when peak occured) was scored dichotomously (before and after 7 am) and compared between OHT converters and non converters patients.&#xD;
One subject was removed from the analysis because of invalid TF output.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acrophase Scored Continuously (i.e. Actual Time of TF Peak Occurrence)</measure>
    <time_frame>24 hours</time_frame>
    <description>Mean TF acrophase (ie. actual time when peak occured) was compared between OHT converters and non converters.&#xD;
One subject was removed from the analysis because of invalid TF output.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amplitude of Best-fitting Cosine Curve to 24-hour TF Measurements</measure>
    <time_frame>24 hours</time_frame>
    <description>This represents an estimate of the magnitude of 24-hour IOP-related variation. One subject was removed from the analysis because of invalid TF output.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Ocular Hypertension</condition>
  <arm_group>
    <arm_group_label>Ocular hypertension subjects</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All subjects will be monitored by Sensimed Triggerfish (TF) for 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sensimed Triggersfish® (TF)</intervention_name>
    <description>All subjects will be monitored by Sensimed Triggerfish (TF) for 24 hours.</description>
    <arm_group_label>Ocular hypertension subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of OHT (IOP &gt;21 mmHg on 2 consecutive visits) in the study eye&#xD;
&#xD;
          -  No IOP-lowering drug treatment in the study eye; otherwise, a 4-week wash-out period&#xD;
             prior to study day 0 (SD0) and throughout the study&#xD;
&#xD;
          -  Aged ≥ 18 years, of either sex&#xD;
&#xD;
          -  Not more than 6 diopters spherical equivalent in the study eye&#xD;
&#xD;
          -  Having given written informed consent, prior to any investigational procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Narrow iridocorneal angle or any other concomitant ocular conditions (except cataract)&#xD;
             in the study eye&#xD;
&#xD;
          -  History of ocular surgery on the study eye (except cataract extraction)&#xD;
&#xD;
          -  History of laser treatment on the study eye&#xD;
&#xD;
          -  Corneal or conjunctival abnormality in the study eye, precluding contact lens&#xD;
             adaptation&#xD;
&#xD;
          -  Severe dry eye syndrome&#xD;
&#xD;
          -  Subjects with irregular sleep schedules&#xD;
&#xD;
          -  Subjects who are current smokers&#xD;
&#xD;
          -  Subjects with allergy to corneal anesthetic&#xD;
&#xD;
          -  Subjects with contraindications for silicone contact lens wear&#xD;
&#xD;
          -  Subjects not able to understand the character and individual consequences of the&#xD;
             investigation&#xD;
&#xD;
          -  Participation in other clinical research within the last 4 weeks&#xD;
&#xD;
          -  Any other contra-indication listed in the TF user manual&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ji Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale Medical School</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>December 30, 2013</study_first_submitted>
  <study_first_submitted_qc>January 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2014</study_first_posted>
  <results_first_submitted>August 14, 2020</results_first_submitted>
  <results_first_submitted_qc>September 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 25, 2020</results_first_posted>
  <last_update_submitted>September 28, 2020</last_update_submitted>
  <last_update_submitted_qc>September 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ocular Hypertension Non Converters</title>
          <description>Stable ocular hypertension patients monitored by Triggerfish (TF) for 24 hours.</description>
        </group>
        <group group_id="P2">
          <title>Ocular Hypertension Converters</title>
          <description>Ocular hypertension patients who progressed to glaucoma monitored by TF for 24 hours</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Stable ocular hypertension patients and ocular hypertension patients who progressed to glaucoma, both monitored by TF for 24 hours.</population>
      <group_list>
        <group group_id="B1">
          <title>Ocular Hypertension Non Converters</title>
          <description>Stable ocular hypertension patients monitored by TF for 24 hours.</description>
        </group>
        <group group_id="B2">
          <title>Ocular Hypertension Converters</title>
          <description>Ocular hypertension patients who progressed to glaucoma monitored by TF for 24 hours.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.3" spread="10.9"/>
                    <measurement group_id="B2" value="59.3" spread="6.7"/>
                    <measurement group_id="B3" value="58.7" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Relationship Between Intraocular Pressure (IOP) Pattern as Recorded by TF, and Quantified by Acrophase Scored Dichotomously, and Conversion to Glaucoma in Ocular Hypertension (OHT) Patients (Conversion Status)</title>
        <description>For each subject, TF acrophase (ie. time when peak occured) was scored dichotomously (before and after 7 am) and compared between OHT converters and non converters patients.&#xD;
One subject was removed from the analysis because of invalid TF output.</description>
        <time_frame>24 hours</time_frame>
        <population>Stable ocular hypertension patients and ocular hypertension patients who progressed to glaucoma both monitored by TF for 24 hours. One subject was removed from the analysis because of invalid TF output.</population>
        <group_list>
          <group group_id="O1">
            <title>Ocular Hypertension Non Converters</title>
            <description>Stable ocular hypertension patients monitored by TF for 24 hours</description>
          </group>
          <group group_id="O2">
            <title>Ocular Hypertension Converters</title>
            <description>Ocular hypertension patients who progressed to glaucoma monitored by TF for 24 hours</description>
          </group>
        </group_list>
        <measure>
          <title>Relationship Between Intraocular Pressure (IOP) Pattern as Recorded by TF, and Quantified by Acrophase Scored Dichotomously, and Conversion to Glaucoma in Ocular Hypertension (OHT) Patients (Conversion Status)</title>
          <description>For each subject, TF acrophase (ie. time when peak occured) was scored dichotomously (before and after 7 am) and compared between OHT converters and non converters patients.&#xD;
One subject was removed from the analysis because of invalid TF output.</description>
          <population>Stable ocular hypertension patients and ocular hypertension patients who progressed to glaucoma both monitored by TF for 24 hours. One subject was removed from the analysis because of invalid TF output.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before 7 am</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3"/>
                    <measurement group_id="O2" value="66.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 7 am</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7"/>
                    <measurement group_id="O2" value="33.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Acrophase Scored Continuously (i.e. Actual Time of TF Peak Occurrence)</title>
        <description>Mean TF acrophase (ie. actual time when peak occured) was compared between OHT converters and non converters.&#xD;
One subject was removed from the analysis because of invalid TF output.</description>
        <time_frame>24 hours</time_frame>
        <population>Stable ocular hypertension patients and ocular hypertension patients who progressed to glaucoma both monitored by TF for 24 hours.&#xD;
One subject was removed from the analysis because of invalid TF output.</population>
        <group_list>
          <group group_id="O1">
            <title>Ocular Hypertension Non Converters</title>
            <description>Stable ocular hypertension patients monitored by TF for 24 hours</description>
          </group>
          <group group_id="O2">
            <title>Ocular Hypertension Converters</title>
            <description>Ocular hypertension patients who progressed to glaucoma monitored by TF for 24 hours</description>
          </group>
        </group_list>
        <measure>
          <title>Acrophase Scored Continuously (i.e. Actual Time of TF Peak Occurrence)</title>
          <description>Mean TF acrophase (ie. actual time when peak occured) was compared between OHT converters and non converters.&#xD;
One subject was removed from the analysis because of invalid TF output.</description>
          <population>Stable ocular hypertension patients and ocular hypertension patients who progressed to glaucoma both monitored by TF for 24 hours.&#xD;
One subject was removed from the analysis because of invalid TF output.</population>
          <units>hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.35" spread="2.01"/>
                    <measurement group_id="O2" value="6.30" spread="3.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amplitude of Best-fitting Cosine Curve to 24-hour TF Measurements</title>
        <description>This represents an estimate of the magnitude of 24-hour IOP-related variation. One subject was removed from the analysis because of invalid TF output.</description>
        <time_frame>24 hours</time_frame>
        <population>Stable ocular hypertension patients and ocular hypertension patients who progressed to glaucoma, both monitored by TF for 24 hours.&#xD;
One subject was removed from the analysis because of invalid TF output.</population>
        <group_list>
          <group group_id="O1">
            <title>Ocular Hypertension Non Converters</title>
            <description>Stable ocular hypertension patients</description>
          </group>
          <group group_id="O2">
            <title>Ocular Hypertension Converters</title>
            <description>Ocular hypertension patients who progressed to glaucoma</description>
          </group>
        </group_list>
        <measure>
          <title>Amplitude of Best-fitting Cosine Curve to 24-hour TF Measurements</title>
          <description>This represents an estimate of the magnitude of 24-hour IOP-related variation. One subject was removed from the analysis because of invalid TF output.</description>
          <population>Stable ocular hypertension patients and ocular hypertension patients who progressed to glaucoma, both monitored by TF for 24 hours.&#xD;
One subject was removed from the analysis because of invalid TF output.</population>
          <units>mVEq</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126.9" spread="52.6"/>
                    <measurement group_id="O2" value="128.0" spread="49.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Within the 24h recording</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Ocular Hypertension Non Converters</title>
          <description>Stable ocular hypertension patients monitored by TF for 24 hours. One subject was removed from the analysis because of invalid TF output.</description>
        </group>
        <group group_id="E2">
          <title>Ocular Hypertension Converters</title>
          <description>Ocular hypertension patients who progressed to glaucoma monitored by TF for 24 hours</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>Upper lid swelling</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Upper lid swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr James Liu</name_or_title>
      <organization>Yale School of Medicine</organization>
      <phone>+1 203 785 2020</phone>
      <email>liu.ji@yale.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

